Back to search

Article

Role of Circulating Free DNA in Evaluating Clinical Tumor Burden and Predicting Survival in Chinese Metastatic Colorectal Cancer Patients

2020-10-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold>The aim of this study was to explore the utility of circulating free DNA (cfDNA) in the evaluation of clinical tumor burden and survival in Chinese patients with metastatic colorectal cancer (mCRC) and to preliminarily summarize some metastatic characteristics associated with mutational status.<bold>Methods:</bold>A panel covering a total of 197 hotspot mutations...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6994e96c-1f9f-5380-9166-524c71475655
DOI
10.21203/rs.3.rs-30475/v4
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Role of Circulating Free DNA in Evaluating Clinical Tumor Burden and Predicting Survival in Chinese Metastatic Colorectal Cancer PatientsDOI 10.21203/rs.3.rs-30475/v4
Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancerSemantic proximity
RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.Semantic proximity
Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer.Semantic proximity
Treatment monitoring of colorectal cancer by integrated analysis of plasma concentration and sequencing of circulating tumor DNA.Semantic proximity
The Clinical Impact of Quantitative Cell-free DNA, KRAS, and BRAF Mutations on Response to Anti-EGFR Treatment in Patients with Metastatic Colorectal Cancer.Semantic proximity
Prognostic and Predictive Value of Circulating Tumor DNA in Patients with Advanced Colorectal Cancer and ChemotherapySemantic proximity
Clinical utility of circulating tumor DNA for colorectal cancerSemantic proximity
Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.Semantic proximity
Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy.Semantic proximity
Clinical Utility of Analyzing Circulating Tumor DNA in Patients with Metastatic Colorectal CancerSemantic proximity
Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA.Semantic proximity
Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer.Semantic proximity
Select a neighboring publication to make it the new centre.